Literature DB >> 2793313

Toxicity of intravitreal oxiconazole.

J A Schulman1, G A Peyman, J Dietlein, R Fiscella.   

Abstract

Oxiconazole, a new imidazole derivative, has a broad antifungal spectrum in vitro and in vivo. Adult New Zealand white rabbits were injected intravitreally with doses ranging from 10 to 100 micrograms of this drug. Eyes were evaluated with preoperative and postoperative biomicroscopy and indirect ophthalmoscopy, electroretinography, and light microscopy. From these data, it was determined that an intravitreal injection containing a concentration of up to 100 micrograms per 0.1 milliliter of oxiconazole was nontoxic to the rabbit eye.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2793313     DOI: 10.1007/bf02028210

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  11 in total

1.  Therapy of postsurgical fungal endophthalmitis.

Authors:  D B Jones
Journal:  Ophthalmology       Date:  1978-04       Impact factor: 12.079

2.  In vitro susceptibility studies with oxiconazole (Ro 13-8996).

Authors:  R J Gebhart; A Espinel-Ingroff; S Shadomy
Journal:  Chemotherapy       Date:  1984       Impact factor: 2.544

3.  Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic.

Authors:  T H Pettit; R J Olson; R Y Foos; W J Martin
Journal:  Arch Ophthalmol       Date:  1980-06

4.  Successful treatment of postoperative Candida endophthalmitis in an eye with an intraocular lens implant.

Authors:  C M Gilbert; M A Novak
Journal:  Am J Ophthalmol       Date:  1984-05       Impact factor: 5.258

5.  Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.

Authors:  F C Odds; C E Webster; A B Abbott
Journal:  J Antimicrob Chemother       Date:  1984-08       Impact factor: 5.790

6.  Candida endophthalmitis in a heroin addict: a case report.

Authors:  J F Salmon; B M Partridge; D J Spalton
Journal:  Br J Ophthalmol       Date:  1983-05       Impact factor: 4.638

7.  Intraocular penetration of systemically administered antifungal agents.

Authors:  D M O'Day; W S Head; R D Robinson; W H Stern; J M Freeman
Journal:  Curr Eye Res       Date:  1985-02       Impact factor: 2.424

8.  Antifungal activity of four antifungal drugs in the cutaneous retention time test.

Authors:  A Polak
Journal:  Sabouraudia       Date:  1984

9.  Oxiconazole, a new imidazole derivative. Evaluation of antifungal activity in vitro and in vivo.

Authors:  A Polak
Journal:  Arzneimittelforschung       Date:  1982

10.  Endophthalmitis: current approaches.

Authors:  J J Rowsey; D L Newsom; D J Sexton; W K Harms
Journal:  Ophthalmology       Date:  1982-09       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.